CTIS2022-502532-38-01招募中1 期
Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study. The PRADO study - 18CH052
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patient requiring primary hip arthroplasty (less than 3 months), Consent of the patient or a family member or the support person
排除标准
- •Contraindication to tranexamic acid, Contraindication to apixaban, Pregnancy, Patient receiving a curative anticoagulating treatment in the preoperative period, Bilateral or previous hip arthroplasty, Hemorrhagic surgery less than 2 weeks old
研究者
相似试验
已完成
4 期
Tranexamic Acid in Total Hip Arthroplasty.Hip ArthroplastyNCT02252497Centre Hospitalier Universitaire de Saint Etienne168
进行中（未招募）
不适用
Tranexamic acid in total hip arthroplastyRBR-75bwryInstituto Nacional de Traumatologia e Ortopedia
已完成
2 期
A Dose-response Study of Tranexamic Acid in Total Hip ArthroplastyArthropathy of HipNCT03822793Centre Hospitalier Universitaire de Saint Etienne170
已完成
4 期
Tranexamic Acid in Lower Limb Arthroplasty Pilot TrialHip or knee joint replacementAnaesthesiology - AnaestheticsSurgery - Other surgeryMusculoskeletal - OsteoarthritisACTRN12613000323729Royal Adelaide Hospital140
已完成
不适用
Effects of tranexamic acid in total knee arthroplasty - pilot studyISRCTN43363116Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)30